M

Mark A. Keibler

Alnylam Pharmaceuticals (United States)

ORCID: 0000-0002-5410-6543

39 papers and 2.6k citations.

PubIndex Score8Top 92% · mid-careerHow it's scored
39Publications
2.6kTotal Citations
First publication: 2011First senior author: 2014